Avalo Therapeutics

-$0.0007 (-0.22%) Today
-$0.0193 (-6.04%) As of 8:41 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVTX and other ETFs, options, and stocks.

About AVTX

Avalo Therapeutics, Inc. is a biopharmaceutical company. engages in the development and commercialization of treatments for rare and orphan diseases. Its lead product candidates include CERC-801, CERC-802, and CERC-803, which are therapies for inherited metabolic disorders known as congenital disorders of glycosylation.

CEO
Garry Arthur Neil
Employees
44
Headquarters
Rockville, Maryland
Founded
2011

AVTX Key Statistics

Market cap
36.02M
Price-Earnings ratio
—
Dividend yield
—
Average volume
384.55K
High today
$0.3284
Low today
$0.30
Open price
$0.32
Volume
194.74K
52 Week high
$3.70
52 Week low
$0.2019

AVTX Earnings

-$0.32
-$0.21
-$0.11
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 2, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure